Rising technological advances in heart care, in terms of diverse engineering and design backgrounds, liability, privacy, and financial perspectives essential to succeed in a complex health care system foster the CRT market growth. The global cardiac resynchronization therapy market is predicted to touch USD 4.7 million at a 7.2% CAGR between 2022-2030, reveals the latest Market Research Future (MRFR) report. Cardiac resynchronization therapy or CRT is a method of implanting a device in the chest for making the chambers of the heart contract in an efficient and organized way.